ACTIMAK Trademark

Trademark Overview

On Monday, February 20, 2023, a trademark application was filed for ACTIMAK with the United States Patent and Trademark Office. The USPTO has given the ACTIMAK trademark a serial number of 97801942. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, January 7, 2025. This trademark is owned by AlfaRim Holding B.V.. The ACTIMAK trademark is filed in the Pharmaceutical Products category with the following description:

Radiopharmaceutical products for therapeutic use in the nature of radioactive markers, radioactive substances for medical purposes, radio-isotope markers for therapeutic use
actimak

General Information

Serial Number97801942
Word MarkACTIMAK
Filing DateMonday, February 20, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, January 7, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 7, 2025

Trademark Statements

Goods and ServicesRadiopharmaceutical products for therapeutic use in the nature of radioactive markers, radioactive substances for medical purposes, radio-isotope markers for therapeutic use

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, March 9, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAlfaRim Holding B.V.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDelft 2629JD
NL
Party NameAlfaRim Holding B.V.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDelft 2629JD
NL

Trademark Events

Event DateEvent Description
Thursday, February 23, 2023NEW APPLICATION ENTERED
Thursday, March 9, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 17, 2023ASSIGNED TO EXAMINER
Friday, November 17, 2023NON-FINAL ACTION WRITTEN
Friday, November 17, 2023NON-FINAL ACTION E-MAILED
Friday, November 17, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, February 16, 2024APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, February 16, 2024APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Monday, May 6, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, September 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, September 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 18, 2024NOTIFICATION OF FINAL REFUSAL EMAILED
Wednesday, September 18, 2024FINAL REFUSAL WRITTEN
Wednesday, September 18, 2024FINAL REFUSAL E-MAILED
Wednesday, September 18, 2024ASSIGNED TO LIE
Monday, November 25, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, November 25, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 25, 2024TEAS REQUEST FOR RECONSIDERATION RECEIVED
Sunday, December 1, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 5, 2024ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Wednesday, January 1, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 7, 2025PUBLISHED FOR OPPOSITION
Tuesday, January 7, 2025OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Related Keywords

actimak radioactive therapeutic markers purposes radio isotope medical substances products radiopharmaceutical